Cipta Sarana Medika Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 4.5× Cipta Sarana Medika Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | RSCH | |
|---|---|---|
Market Cap | 158.12B | 715.5B |
Volume | 8.21M | 30.64M |
Lot | 82.15K | 306.41K |
Turnover | 515.2M | 7.98B |
Average Price | 62.72 | 260.34 |
Value | 515.2M | 7.98B |
Indicative Equilibrium Price | 63 | 256 |
Indicative Equilibrium Volume | 1.33K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →